Singapore infrastructure service provider Vistek (VTEK.US) increases IPO size by 66%, aiming to raise $31 million.
Singapore power and telecommunication network cable laying service provider Vistek has increased the target fund size for its upcoming US IPO on Tuesday.
Singaporean power and communication network cable laying service provider Vistek (VTEK.US) has increased the planned fundraising size for its upcoming IPO in the United States on Tuesday. The Singapore-based company is now planning to issue 6.3 million shares of stock (with 40% as secondary selling shares), at a price range of $4-6 per share, aiming to raise $31 million.
Earlier this year, the company had applied to issue 3.8 million shares (with 30% as secondary selling shares) at the same price, raising $19 million; it initially submitted an IPO application in January 2025, planning to raise $10 million. Based on the midpoint of the price range, Vistek's fundraising amount this time will be about 66% higher than previously expected, with a market value of $120 million after listing.
Established in 2017, Vistek had revenue of $19 million in the 12 months ending on August 31, 2025. The company plans to list on the Nasdaq under the ticker symbol VTEK, with Bancroft Capital serving as the exclusive underwriter for this IPO.
Related Articles

JIANGSU EXPRESS (00177) has announced its performance for 2025, with a net profit attributable to shareholders of approximately RMB 4.594 billion, representing a year-on-year decrease of about 7.13%.

New Stock News | Aqara International Ltd. Submits Application to Hong Kong Stock Exchange

TOP SPRING (03688) issues profit warning, expecting a net loss of HKD 3 billion for the year 2025.
JIANGSU EXPRESS (00177) has announced its performance for 2025, with a net profit attributable to shareholders of approximately RMB 4.594 billion, representing a year-on-year decrease of about 7.13%.

New Stock News | Aqara International Ltd. Submits Application to Hong Kong Stock Exchange

TOP SPRING (03688) issues profit warning, expecting a net loss of HKD 3 billion for the year 2025.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


